순환기과용 전자건강기록(EHR) 시장 : 규모, 점유율, 동향 분석, 제품별, 비즈니스 모델별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Cardiology EHR Market Summary

The global cardiology EHR market size was estimated at USD 3.16 billion in 2024, and is projected to reach USD 4.83 billion by 2033, growing at a CAGR of 4.9% from 2025 to 2033. The growing focus on improved patient care, the need for long-term patient record tracking, improved clinical decision-making, and technological advancements contribute to market growth.

This growth is further propelled by the escalating global burden of cardiovascular diseases (CVDs). For instance, according to the WHO, cardiovascular diseases (CVDs) are one of the highest causes of death globally, accounting for approximately 17.9 million deaths each year. Enhanced patient care in cardiology is further driving the market. Electronic health records allow healthcare providers to maintain a detailed and accessible history of a patient's cardiovascular health, enabling timely diagnosis and personalized treatment plans. In addition, tracking long-term historical patient data is important in cardiology, where managing chronic conditions and monitoring progress over time is critical. Electronic Health Record (EHR) systems facilitate this by consolidating data from multiple visits, tests, and procedures into a comprehensive digital file.

Moreover, in response to the need for better chronic disease management, the U.S. government introduced several mandates to accelerate the adoption of EHR systems. These policies aimed to improve care coordination, enable data-driven decisions, and enhance preventive care, especially for conditions such as cardiovascular disease. The article "Policy Strategies to Advance Cardiovascular Health in the United States" by Wadhera and Joynt Maddox, published in the American Heart Association in April 2024, examines U.S. health policies to improve cardiovascular health. It highlights the impact of the Affordable Care Act in expanding preventive services and discusses ongoing challenges and strategies to enhance cardiovascular outcomes through policy interventions.

Furthermore, aligning with these national efforts, in June 2024, Athenahealth and Cardiovascular Associates of America (CVAUSA) partnered to support independent cardiologists in delivering value-based care. CVAUSA-affiliated practices gain preferred access to athenaOne, an electronic health record (EHR) suite, revenue cycle management (RCM), and patient engagement solutions. This collaboration aims to enhance clinical and financial performance, streamline operations, and leverage data-driven insights to improve patient outcomes and practice sustainability.

Technological innovations are significantly accelerating market growth by improving these systems' functionality, usability, and integration capabilities. Advances such as cloud-based platforms and artificial intelligence (AI) enable more efficient data management and deeper insights into patient health trends. For instance, Oracle Health is set to launch a next-generation electronic health record (EHR) platform in 2025. The platform is expected to integrate AI-driven tools such as a Clinical AI Agent, voice navigation, and Health Data Intelligence. Built on Oracle Cloud Infrastructure, it aims to enhance clinical workflows, support personalized care, and advance value-based healthcare delivery.

Global Cardiology EHR Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cardiology EHR market report based on product, business model, end use, and region:

• Product Outlook (Revenue, USD Billion, 2021 - 2033)
• Web/ cloud-based EHR
• On-premise EHR
• Business Model Outlook (Revenue, USD Billion, 2021 - 2033)
• Licensed Software
• Technology Resale
• Subscriptions
• Professional Services
• Others (Support & Maintenance, Managed Services, etc.)
• End Use Size Outlook (Revenue, USD Billion, 2021 - 2033)
• Hospital
• Ambulatory Surgical Centers
• Other end use
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Business Model
  • 1.2.3. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increase in need for improved patient care
    • 3.2.1.2. Government Initiatives and Regulations
    • 3.2.1.3. Advancements in Technology
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Implementation and Maintenance Costs
    • 3.2.2.2. Data Privacy and Security Concerns
• 3.3. Case Studies
• 3.4. Business Environment Analysis
  • 3.4.1. Porter's Five Forces Analysis
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTLE Analysis

Chapter 4. Product Business Analysis

• 4.1. Product Market Share, 2024 & 2033
• 4.2. Product Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Billion)
• 4.4. Web/Cloud-Based EHR
  • 4.4.1. Web/cloud Based EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
• 4.5. On-premise EHR
  • 4.5.1. On-premise EHR market estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Business Model Business Analysis

• 5.1. Business Model Market Share, 2024 & 2033
• 5.2. Business Model Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analyses, by Business Model, 2021 to 2033 (USD Billion)
• 5.4. Licensed Software
  • 5.4.1. Licensed software market estimates and forecasts, 2021 - 2033 (USD Billion)
• 5.5. Technology Resale
  • 5.5.1. Technology resale market estimates and forecasts, 2021 - 2033 (USD Billion)
• 5.6. Subscriptions
  • 5.6.1. Subscriptions market estimates and forecasts, 2021 - 2033 (USD Billion)
• 5.7. Professional Services
  • 5.7.1. Professional services market estimates and forecasts, 2021 - 2033 (USD Billion)
• 5.8. Others (Support & Maintenance, Managed Services, etc.)
  • 5.8.1. Others (Support & Maintenance, Managed Services, etc.) market estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 6. End Use Business Analysis

• 6.1. End Use Market Share, 2024 & 2033
• 6.2. End Use Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analyses, by End Use, 2021 to 2033 (USD Billion)
• 6.4. Hospital
  • 6.4.1. Hospital market estimates and forecasts, 2021 - 2033 (USD Billion)
• 6.5. Ambulatory Surgical Centers
  • 6.5.1. Ambulatory Surgical Centers market estimates and forecasts, 2021 - 2033 (USD Billion)
• 6.6. Other end use
  • 6.6.1. Other end use market estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Regional Estimates & Trend Analysis by Product, Business Model, End Use

• 7.1. Regional Market Share Analysis, 2024 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
• 7.4. North America
  • 7.4.1. North America Cardiology EHR Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.4.2. U.S.
    • 7.4.2.1. Key country dynamic
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive insights
    • 7.4.2.4. U.S. cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.4.3. Canada
    • 7.4.3.1. Key country dynamic
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive insights
    • 7.4.3.4. Canada cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.4.4. Mexico
    • 7.4.4.1. Key country dynamic
    • 7.4.4.2. Regulatory framework
    • 7.4.4.3. Competitive insights
    • 7.4.4.4. Mexico cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
• 7.5. Europe
  • 7.5.1. Europe Cardiology EHR Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.5.2. Germany
    • 7.5.2.1. Key country dynamic
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive insights
    • 7.5.2.4. Germany cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.5.3. UK
    • 7.5.3.1. Key country dynamic
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive insights
    • 7.5.3.4. UK cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.5.4. France
    • 7.5.4.1. Key country dynamic
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive insights
    • 7.5.4.4. France cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.5.5. Italy
    • 7.5.5.1. Key country dynamic
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive insights
    • 7.5.5.4. Italy cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.5.6. Spain
    • 7.5.6.1. Key country dynamic
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive insights
    • 7.5.6.4. Spain cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.5.7. Denmark
    • 7.5.7.1. Key country dynamic
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Competitive insights
    • 7.5.7.4. Denmark cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.5.8. Sweden
    • 7.5.8.1. Key country dynamic
    • 7.5.8.2. Regulatory framework
    • 7.5.8.3. Competitive insights
    • 7.5.8.4. Sweden cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.5.9. Norway
    • 7.5.9.1. Key country dynamic
    • 7.5.9.2. Regulatory framework
    • 7.5.9.3. Competitive insights
    • 7.5.9.4. Norway cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Cardiology EHR Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.6.2. Japan
    • 7.6.2.1. Key country dynamic
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive insights
    • 7.6.2.4. Japan cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.6.3. China
    • 7.6.3.1. Key country dynamic
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive insights
    • 7.6.3.4. China cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.6.4. India
    • 7.6.4.1. Key country dynamic
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Competitive insights
    • 7.6.4.4. India cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.6.5. South Korea
    • 7.6.5.1. Key country dynamic
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Competitive insights
    • 7.6.5.4. South Korea cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.6.6. Australia
    • 7.6.6.1. Key country dynamic
    • 7.6.6.2. Regulatory framework
    • 7.6.6.3. Competitive insights
    • 7.6.6.4. Australia cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.6.7. Thailand
    • 7.6.7.1. Key country dynamic
    • 7.6.7.2. Regulatory framework
    • 7.6.7.3. Competitive insights
    • 7.6.7.4. Thailand cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
• 7.7. Latin America
  • 7.7.1. Latin America Cardiology EHR Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.7.2. Brazil
    • 7.7.2.1. Key country dynamic
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive insights
    • 7.7.2.4. Brazil cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.7.3. Argentina
    • 7.7.3.1. Key country dynamic
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive insights
    • 7.7.3.4. Argentina cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
• 7.8. MEA
  • 7.8.1. MEA Cardiology EHR Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.8.2. South Africa
    • 7.8.2.1. Key country dynamic
    • 7.8.2.2. Regulatory framework
    • 7.8.2.3. Competitive insights
    • 7.8.2.4. South Africa cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key country dynamic
    • 7.8.3.2. Regulatory framework
    • 7.8.3.3. Competitive insights
    • 7.8.3.4. Saudi Arabia cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.8.4. UAE
    • 7.8.4.1. Key country dynamic
    • 7.8.4.2. Regulatory framework
    • 7.8.4.3. Competitive insights
    • 7.8.4.4. UAE cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key country dynamic
    • 7.8.5.2. Regulatory framework
    • 7.8.5.3. Competitive insights
    • 7.8.5.4. Kuwait cardiology EHR market estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Epic Systems Corporation
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial performance
    • 8.5.1.3. Product benchmarking
    • 8.5.1.4. Strategic initiatives
  • 8.5.2. Oracle
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial performance
    • 8.5.2.3. Product benchmarking
    • 8.5.2.4. Strategic initiatives
  • 8.5.3. Veradigm LLC
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial performance
    • 8.5.3.3. Product benchmarking
    • 8.5.3.4. Strategic initiatives
  • 8.5.4. GE HealthCare.
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial performance
    • 8.5.4.3. Product benchmarking
    • 8.5.4.4. Strategic initiatives
  • 8.5.5. Philips Healthcare
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial performance
    • 8.5.5.3. Product benchmarking
    • 8.5.5.4. Strategic initiatives
  • 8.5.6. McKesson Corporation
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial performance
    • 8.5.6.3. Product benchmarking
    • 8.5.6.4. Strategic initiatives
  • 8.5.7. eClinicalWorks
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Product benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. NextGen Healthcare, Inc.
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Product benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. athenahealth, Inc.
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Product benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. Greenway Health, LLC
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Product benchmarking
    • 8.5.10.4. Strategic initiatives